公开(公告)号：US20240398885A1

公开(公告)日：2024-12-05

申请号：US18694262

申请日：2022-12-08

Applicant: Coty Inc.

Inventor： Olivier Doucet ,  Cécile Chamayou-Robert ,  Muriel Pujos

IPC: A61K36/31 ,  A61K8/44 ,  A61K8/9789 ,  A61K8/99 ,  A61K9/127 ,  A61K31/198 ,  A61K35/68 ,  A61K35/74 ,  A61K38/47 ,  A61K38/51 ,  A61P17/00 ,  A61P39/06 ,  A61Q19/08

Abstract: Provided herein is a method to treat skin damage due to light comprising topically administering to a subject in need thereof a composition comprising a sufficient amount of Arabidopsis thaliana extract, micrococcus lysate and plankton extract to simultaneously treat the damage caused by skin exposure to UVA, UVB, infrared light, visible light or a combination thereof.

公开(公告)号：US20240398883A1

公开(公告)日：2024-12-05

申请号：US18241480

申请日：2023-09-01

Applicant: YU-TE LIU

Inventor： YU-TE LIU ,  Tsai-Ching HSU ,  Bor-Show TZANG

IPC: A61K36/232 ,  A61K33/04 ,  A61K36/31 ,  A61K36/539 ,  A61K36/736 ,  A61P35/00

Abstract: A Chinese medicine composition for treating lung cancer and a preparation method thereof. The Chinese medicine combination includes Bai Zhi (Angelica dahurica), Huang Qin (Scutellaria baicalensis), Ting Li Zi (Lepidium apetalum), Xing Ren (Apricot kernel), and Mang Xiao (Mirabilite). The content of each ingredients is measured by weight, with Bai Zhi ranging from 3 to 30 parts by weight, Huang Qin ranging from 3 to 30 parts by weight, Ting Li Zi ranging from 8 to 35 parts by weight, Xing Ren ranging from 5 to 30 parts by weight, and Mang Xiao ranging from 0.3 to 5 parts by weight. Cellular experiments have confirmed that when the Chinese medicine composition at an effective dosage of 1 to 100 μg/ml is administered to the lung cancer cells in vitro, LC3-I/LC3-II proteins are induced to express, thereby triggering autophagy in the lung cancer cells to inhibit or reduce cell activity.

公开(公告)号：US20240398857A1

公开(公告)日：2024-12-05

申请号：US18677013

申请日：2024-05-29

Applicant: PAPILLEX INC.

Inventor： Elizabeth GOLDSPINK

IPC: A61K33/30 ,  A61K31/07 ,  A61K31/353 ,  A61K31/375 ,  A61K31/519 ,  A61K31/714 ,  A61K33/04 ,  A61K36/074 ,  A61K36/31 ,  A61K36/481 ,  A61K36/82 ,  A61K45/06 ,  A61P31/20

Abstract: A composition for the management of Human Papillomavirus (HPV) infections is provided. The composition comprises a combination of activated folate, one or more zinc compounds such as zinc sulfate, a phenol catechin such as Epigallocatechin-3-gallate (EGCG), broccoli seed or sprout, and one or more carotenoids. The composition may comprise one or more mushrooms or mushroom extracts. The composition may be useful for the control of symptoms associated with HPV infection in one or more individuals, and may also include reducing the frequency and/or persistence of HPV related conditions.

公开(公告)号：US20240316134A1

公开(公告)日：2024-09-26

申请号：US18573049

申请日：2023-03-29

Applicant: KINJIRUSHI CO., LTD.

Inventor： Ryuta Kawashima ,  Rui Nouchi ,  Isao Okunishi

IPC: A61K36/31 ,  A61K9/00 ,  A61K9/48 ,  A61K31/26 ,  A61P25/28

CPC classification number: A61K36/31 ,  A61K9/0053 ,  A61K9/4866 ,  A61K31/26 ,  A61P25/28

Abstract: A blood flow increasing agent for dorsolateral prefrontal cortex includes 6-methylsulfinylhexyl isothiocyanate.

公开(公告)号：US20240285721A1

公开(公告)日：2024-08-29

申请号：US18659701

申请日：2024-05-09

Applicant: HAUS BIOCEUTICALS, INC.

Inventor： Tomy YESUDAS ,  Philip ALEX ,  Michael CENTOLA ,  Adam Joshua PAYNE

IPC: A61K36/90 ,  A61K36/185 ,  A61K36/22 ,  A61K36/23 ,  A61K36/24 ,  A61K36/27 ,  A61K36/28 ,  A61K36/29 ,  A61K36/31 ,  A61K36/35 ,  A61K36/48 ,  A61K36/66 ,  A61K36/68 ,  A61K36/71 ,  A61K36/76 ,  A61K36/77 ,  A61K36/808 ,  A61K36/899

CPC classification number: A61K36/90 ,  A61K36/185 ,  A61K36/22 ,  A61K36/23 ,  A61K36/24 ,  A61K36/27 ,  A61K36/28 ,  A61K36/29 ,  A61K36/31 ,  A61K36/35 ,  A61K36/48 ,  A61K36/66 ,  A61K36/68 ,  A61K36/71 ,  A61K36/76 ,  A61K36/77 ,  A61K36/808 ,  A61K36/899

Abstract: Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.

公开(公告)号：US12048712B2

公开(公告)日：2024-07-30

申请号：US18381558

申请日：2023-10-18

Applicant: Bonafide Health, LLC

Inventor： James R. Komorowski ,  Sarah Sylla ,  Devon Bernsley

IPC: A61K36/00 ,  A61K31/235 ,  A61K31/7076 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/16 ,  A61P13/06

CPC classification number: A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/168 ,  A61P13/06

Abstract: Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.

公开(公告)号：US20240216455A1

公开(公告)日：2024-07-04

申请号：US17916806

申请日：2021-07-23

Applicant: ANUPAM GUPTA

Inventor： ANUPAM GUPTA

IPC: A61K36/31 ,  A61K9/00 ,  A61K33/04 ,  A61K33/14 ,  A61K33/42 ,  A61K36/54 ,  A61K36/9066

CPC classification number: A61K36/31 ,  A61K9/0014 ,  A61K33/04 ,  A61K33/14 ,  A61K33/42 ,  A61K36/54 ,  A61K36/9066

Abstract: The embodiments relate to a non-steroidal topical formulation comprising 10 wt % to 20 wt % of an active ingredient consisting of a combination of group I and group II component and 80 wt % to 90 wt % of inactive ingredient comprising one or more pharmaceutically acceptable excipient. The group I component maybe a plant extract obtained from Curcuma spp, Litsea spp., and Lepidium spp. and group II component may be selected from a group comprising Potassium sulfate (Kali sulphuricum), Potassium Phosphate (Kali phosphoricum), Sodium sulfate (Natrum sulphuricum, Sodium chloride (Natrum phosphoricum), Potassium Chloride (Kali muriaticum), and Sodium Phosphate (Natrum phosphoricum). The said formulation is capable of efficiently eliminating or reducing age-related osteoarthritic joint pain, inflammation and musculoskeletal diseases and provides long-term relief to the aged patients. Another preferred embodiment of the present invention relates to a method of preparing the said formulation.

公开(公告)号：US12005095B2

公开(公告)日：2024-06-11

申请号：US17177016

申请日：2021-02-16

Applicant: Givaudan France Naturals SAS ,  AVIGNON UNIVERSITÉ

Inventor： Alexis Lavaud ,  Michael Laguerre ,  Simona Birtic ,  Anne Sylvie Fabiano Tixier ,  Marc Roller ,  Farid Chemat ,  Antoine Charles Bily

IPC: A61K36/736 ,  A23L33/105 ,  A61K36/11 ,  A61K36/23 ,  A61K36/31 ,  A61K36/53 ,  A61K36/63 ,  A61K36/88 ,  B01D11/02

CPC classification number: A61K36/736 ,  A23L33/105 ,  A61K36/11 ,  A61K36/23 ,  A61K36/31 ,  A61K36/53 ,  A61K36/63 ,  A61K36/88 ,  B01D11/02 ,  B01D11/0288 ,  A61K2236/331

Abstract: A eutectic extraction solvent for extracting plant (e.g. vegetable) and/or animal and/or prokaryotic biological material, wherein the solvent is a clear, stable and fluid mixture comprising:



(a) betaine or a hydrated form of betaine;
(b) at least one hydrogen bond donor compound selected from the group consisting of polyols and organic acids; and
(c) water
with the proviso that the eutectic extraction solvent does not contain any exogenous sugar and/or amine salt and/or anion.

公开(公告)号：US20240122958A1

公开(公告)日：2024-04-18

申请号：US18381558

申请日：2023-10-18

Applicant: Bonafide Health, LLC

Inventor： James R. Komorowski ,  Sarah Sylla ,  Devon Bernsley

IPC: A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/16 ,  A61P13/06

CPC classification number: A61K31/7076 ,  A61K31/235 ,  A61K36/185 ,  A61K36/31 ,  A61K36/42 ,  A61K36/54 ,  A61K38/168 ,  A61P13/06

Abstract: Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.

公开(公告)号：US11957727B2

公开(公告)日：2024-04-16

申请号：US17395249

申请日：2021-08-05

Applicant: Therapeutic Solutions International, Inc.

Inventor： Thomas E. Ichim ,  Famela Ramos ,  James Veltmeyer ,  Timothy G. Dixon

IPC: A61K36/82 ,  A61K31/09 ,  A61K31/122 ,  A61K31/26 ,  A61K31/353 ,  A61K36/31 ,  A61K36/45 ,  A61K36/71 ,  A61P25/28

CPC classification number: A61K36/82 ,  A61K31/09 ,  A61K31/122 ,  A61K31/26 ,  A61K31/353 ,  A61K36/31 ,  A61K36/45 ,  A61K36/71 ,  A61P25/28

Abstract: Disclosed are means, methods, and therapeutic compositions for prevention of memory loss during situations of neuroinflammation. In one embodiment the invention teaches administration of the therapeutic combination of ingredients comprising of pterostilbene, Nigella sativa, sulforaphane, and epigallocatechin-3-gallate (EGCG) to a mammal suffering from inflammation in order to preserver memory function.